Natera Stock Forecast
NASDAQ: NTRAHealth CareMedical SpecialitiesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NTRA analyst consensus
Consensus (23 analysts)
strong_buy
Avg. price target
$377.43-3.42%
- Strong buy 5
- Buy 16
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 23 Wall Street analysts covering Natera (2026-10-07), 21 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $377.43, with a high estimate of $480.00 and a low estimate of $280.00. The average target implies downside of 3.4% from the current price of $390.79.
The spread between the highest and lowest targets is 71.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for NTRA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 5 | 22% |
| Buy | 16 | 70% |
| Hold | 2 | 9% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $280.00 | -28.35% |
| Average target | $377.43 | -3.42% |
| High target | $480.00 | +22.83% |